JP2017533920A5 - - Google Patents

Download PDF

Info

Publication number
JP2017533920A5
JP2017533920A5 JP2017524349A JP2017524349A JP2017533920A5 JP 2017533920 A5 JP2017533920 A5 JP 2017533920A5 JP 2017524349 A JP2017524349 A JP 2017524349A JP 2017524349 A JP2017524349 A JP 2017524349A JP 2017533920 A5 JP2017533920 A5 JP 2017533920A5
Authority
JP
Japan
Prior art keywords
cancer
situ vaccine
mosaic virus
cowpea mosaic
empty
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017524349A
Other languages
English (en)
Japanese (ja)
Other versions
JP6731405B2 (ja
JP2017533920A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2015/059675 external-priority patent/WO2016073972A1/en
Publication of JP2017533920A publication Critical patent/JP2017533920A/ja
Publication of JP2017533920A5 publication Critical patent/JP2017533920A5/ja
Application granted granted Critical
Publication of JP6731405B2 publication Critical patent/JP6731405B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017524349A 2014-11-07 2015-11-09 ウイルス粒子を用いた癌免疫療法 Active JP6731405B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201462076543P 2014-11-07 2014-11-07
US62/076,543 2014-11-07
US201562107617P 2015-01-26 2015-01-26
US62/107,617 2015-01-26
US201562159389P 2015-05-11 2015-05-11
US62/159,389 2015-05-11
PCT/US2015/059675 WO2016073972A1 (en) 2014-11-07 2015-11-09 Cancer immunotherapy using virus particles

Publications (3)

Publication Number Publication Date
JP2017533920A JP2017533920A (ja) 2017-11-16
JP2017533920A5 true JP2017533920A5 (enExample) 2018-11-22
JP6731405B2 JP6731405B2 (ja) 2020-07-29

Family

ID=55909946

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017524349A Active JP6731405B2 (ja) 2014-11-07 2015-11-09 ウイルス粒子を用いた癌免疫療法

Country Status (7)

Country Link
US (4) US10639363B2 (enExample)
EP (2) EP3957644B1 (enExample)
JP (1) JP6731405B2 (enExample)
CN (1) CN107001428B (enExample)
AU (1) AU2015342790B2 (enExample)
CA (1) CA2967336C (enExample)
WO (2) WO2016073972A1 (enExample)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2906260B1 (en) 2012-10-09 2019-06-26 Case Western Reserve University Rod-shaped plant virus nanoparticles as imaging agent platforms
WO2014113203A1 (en) 2013-01-17 2014-07-24 Case Western Reserve University Viral nanoparticle multimers
US11998594B2 (en) 2014-04-02 2024-06-04 Case Western Reserve University Anti-cancer plant virus particles linked to HER2 antigens
US9925281B2 (en) 2014-08-05 2018-03-27 Case Western Reserve University Coated plant virus imaging agents
US11617787B2 (en) 2014-11-07 2023-04-04 Case Western Reserve University Cancer immunotherapy using virus particles
US12465624B2 (en) 2018-05-08 2025-11-11 Case Western Reserve University Cancer immunotherapy using virus particles and immune checkpoint therapy
EP3957644B1 (en) 2014-11-07 2024-08-07 Case Western Reserve University Cancer immunotherapy using virus particles
WO2017004123A1 (en) 2015-06-29 2017-01-05 Case Western Reserve University Anticancer drug-containing plant virus particles
EP3725332B1 (en) 2015-07-16 2023-10-04 Case Western Reserve University Plant virus particles for delivery of antimitotic agents
US11433123B2 (en) 2016-07-21 2022-09-06 Case Western Reserve University Sustained release cowpea mosaic virus or virus-like particle therapeutic constructs for the treatment of cancer
CA3042695A1 (en) 2016-11-03 2018-05-11 Case Western Reserve University Melt processed viral nanoparticle constructs
US12433840B2 (en) 2016-11-03 2025-10-07 Case Western Reserve University Melt processed viral nanoparticle constructs
US11590183B2 (en) 2017-03-10 2023-02-28 Case Western Reserve University Cancer immunotherapy using virus particles
US11672840B2 (en) 2017-05-17 2023-06-13 Case Western Reserve University Anticancer trail-targeted plant virus particles
WO2019084555A1 (en) 2017-10-27 2019-05-02 Case Western Reserve University TYMOVIRUS VIRUSES AND VIRAL TYPE PARTICLES USEFUL AS NANOVECTORS FOR IMAGING AND THERAPEUTIC AGENTS
US20210030829A1 (en) * 2018-03-06 2021-02-04 University Of Louisville Research Foundation, Inc. Methods for treatment of cancer and enhancement of nanoparticle accumulation in tissues
SG11202106931PA (en) * 2018-12-27 2021-07-29 Verimmune Llc Conjugated virus-like particles and uses thereof as anti-tumor immune redirectors
WO2020180738A1 (en) * 2019-03-01 2020-09-10 The Regents Of The University Of California Cancer immunotherapy
US11390853B2 (en) 2019-04-26 2022-07-19 Case Western Reserve University Freeze dried viral nanoparticle constructs
US11896676B2 (en) 2019-08-07 2024-02-13 Case Western Reserve University Targeting cancer cells and tissue using filamentous plant virus particles
CN110859861A (zh) * 2019-12-04 2020-03-06 武汉工程大学 植物病原微生物杀灭癌细胞或艾滋病病毒的用途
US11529430B2 (en) 2019-12-20 2022-12-20 Case Western Reserve University Polydopamine decorated tobacco mosaic theranostic virus nanoparticles
US12203073B2 (en) 2019-12-20 2025-01-21 Case Western Reserve University Plant viral RNA delivery nanoparticles and uses thereof
WO2022150648A1 (en) * 2021-01-08 2022-07-14 The Regents Of The University Of California Ovarian cancer vaccine
EP4449427A1 (en) 2021-12-15 2024-10-23 Diamante S.r.l. Apparatus for determining administrative form of a composition of an engineered virus-based nanoparticle for a treatment of an autoimmune condition
US20250114444A1 (en) * 2022-01-19 2025-04-10 Universität Bern Compositions of virus-like particles and microcrystalline tyrosine

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5004606A (en) 1986-09-24 1991-04-02 Hybritech Incorporated Non-covalent antibody-anthracycline immunocomplexes
GB9921337D0 (en) * 1999-09-09 1999-11-10 Axis Genetics Plc Modified plant viruses
GB9924351D0 (en) * 1999-10-14 1999-12-15 Brennan Frank Immunomodulation methods and compositions
NZ586071A (en) 2002-05-02 2012-02-24 Wyeth Corp Calicheamicin derivative-carrier conjugates comprising a CD22 antibody
CA2435632A1 (en) * 2003-07-21 2005-01-21 Warren Hugh Finlay Formulation of powder containing nanoparticles for aerosol delivery to the lung
US20070248617A1 (en) 2004-06-02 2007-10-25 Bachmann Martin F Medical Uses of Carrier Conjugates of Non-Human Tnf -Peptides
US20070258889A1 (en) 2005-11-09 2007-11-08 Montana State University Novel nanoparticles and use thereof
MX2008007005A (es) * 2005-12-02 2009-03-04 Dow Global Technologies Inc Particulas de virus de planta nuevos y metodos de inactivacion de estos.
US7771339B2 (en) * 2006-05-31 2010-08-10 Ab Mimator Method and system for radiotherapy treatment
US20100183504A1 (en) 2007-06-14 2010-07-22 Fanqing Frank Chen Multimodal imaging probes for in vivo targeted and non-targeted imaging and therapeutics
WO2016149264A1 (en) 2015-03-18 2016-09-22 The Johns Hopkins University Compositions and methods for sensitizing cells to trail-induced apoptosis
ATE539148T1 (de) * 2009-11-30 2012-01-15 United Cancer Res Inst Neuer klon des geflügelpestvirus, herstellung und anwendung bei der medizinischen behandlung von krebs
WO2012078069A1 (en) 2010-12-09 2012-06-14 Iosif Grigorievich Atabekov Spherical nano- and microparticles derived from plant viruses for the display of foreign proteins or epitopes
US9486834B2 (en) 2011-07-29 2016-11-08 Youtec Co., Ltd. Ferroelectric film and method for manufacturing the same
WO2013158620A1 (en) 2012-04-16 2013-10-24 North Carolina State University Nanotechnology system for agricultural applications
EP2841097B1 (en) 2012-04-24 2022-11-16 Ohio State Innovation Foundation Compositions and methods for treating and preventing porcine reproductive and respiratory syndrome
WO2013181557A1 (en) 2012-05-31 2013-12-05 Case Western Reserve University Targeting cancer cells and tissue using filamentous plant virus particles
EP2906260B1 (en) 2012-10-09 2019-06-26 Case Western Reserve University Rod-shaped plant virus nanoparticles as imaging agent platforms
CN105899217A (zh) * 2013-09-19 2016-08-24 弗利亚生物技术公司 癌症疗法中的番木瓜花叶病毒和病毒样颗粒
WO2015188110A1 (en) 2014-06-05 2015-12-10 The Johns Hopkins University Reversible pegylation for screeing of therapeutic proteins in vivo
ES2839998T3 (es) 2014-08-01 2021-07-06 Gpb Scient Inc Métodos y sistemas para procesar partículas
US9925281B2 (en) 2014-08-05 2018-03-27 Case Western Reserve University Coated plant virus imaging agents
EP3957644B1 (en) * 2014-11-07 2024-08-07 Case Western Reserve University Cancer immunotherapy using virus particles
WO2017004123A1 (en) * 2015-06-29 2017-01-05 Case Western Reserve University Anticancer drug-containing plant virus particles
EP3725332B1 (en) 2015-07-16 2023-10-04 Case Western Reserve University Plant virus particles for delivery of antimitotic agents
US11672840B2 (en) 2017-05-17 2023-06-13 Case Western Reserve University Anticancer trail-targeted plant virus particles

Similar Documents

Publication Publication Date Title
JP2017533920A5 (enExample)
Araste et al. Peptide-based targeted therapeutics: Focus on cancer treatment
Beloqui et al. Mechanisms of transport of polymeric and lipidic nanoparticles across the intestinal barrier
Tang et al. Nonporous silica nanoparticles for nanomedicine application
Mahmoudi et al. Superparamagnetic iron oxide nanoparticles (SPIONs): development, surface modification and applications in chemotherapy
HRP20211177T1 (hr) Korteksolon 17alfa-valerat za uporabu u liječenju tumora
JP2019526543A5 (enExample)
WO2016004048A3 (en) Targeted conjugates and particles and formulations thereof
WO2016161342A3 (en) Nitrobenzyl derivatives of anti-cancer agents
JP2015516989A5 (enExample)
WO2015095227A3 (en) Peptidomimetic compounds and antibody-drug conjugates thereof
NZ710746A (en) Pyrrolobenzodiazepines and conjugates thereof
JP2011079858A5 (enExample)
WO2017194782A3 (en) Therapeutic targeting of non-cellular structures
EP3686200A3 (en) Bicyclic heterocycle compounds and their uses in therapy
CN112888458A (zh) Cldn18的抗体和化疗药物的联合治疗
JP2015502926A5 (enExample)
JP2016528217A5 (enExample)
JP2017508724A5 (enExample)
MX381016B (es) Composiciones de nanopartículas para su uso en la entrega de una carga útil al cerebro.
MY165888A (en) Dry powder formulation comprising a corticosteroid and a beta-adrenergic for administration by inhalation
JP2013533269A5 (enExample)
RU2017141536A (ru) Замещенные производные индол-5-ола и их терапевтические применения
MX2017016183A (es) Vacuna de adn que dirige vegfr-2 para terapia de combinacion.
JP2016526021A5 (enExample)